我国医药制造行业经济运行情况分析

摘要：本文从产业地位、增长态势、行业结构、产品构成和法规管理等五个方面综合分析了我国医药制造行业的经济运行状况。结果发现，医药制造行业经济地位逐渐增强，从2014年的收入13625亿元的 销售总 收入直至2018年的17850亿元，经过四年多的发展，达到了15.9%的年均增长率，2018年全市占据其他制造业企业经营收入总量的 10.7%；行业结构加剧了三类产品的分化，生物制品、药品精制和中间物质分别占总产值的比重分别为45.6%、23.8%和30.6%，三者的增长较快；此外，我国医药制造业的行业标准不断发展和完善，还推出了《药品GMP认证归纳目录》，取得了良好的社会效益。



关键词：医药制造；经济运行；产业地位；增长态势；行业结构

中图分类号： X539

文献标识码： A

Abstract: This paper comprehensively analyzes the economic operation of China's pharmaceutical manufacturing industry from five aspects: industrial status, growth trend, industry structure, product composition and regulatory management. The results show that the economic status of the pharmaceutical manufacturing industry has gradually increased. From the total sales revenue of 1362.5 billion yuan in 2014 to 1785 billion yuan in 2018, after more than four years of development, it reached an annual growth rate of 15.9%, and in 2018 it accounted for 10.7% of the total operating revenue of other manufacturing enterprises in the city. Industry structure has intensified the differentiation of three types of products. The proportion of biological products, refined drugs and intermediate materials to total output value was 45.6%, 23.8% and 30.6%, respectively, and the growth of the three was relatively rapid. In addition, the industry standards of China's pharmaceutical manufacturing industry have been constantly developed and improved, and the "Catalogue of Drug GMP Certification" has been launched, which has achieved good social benefits.

Key Words：Pharmaceutical manufacturing；Economic operation；Industrial status；Growth trend；Industry structure